Investing

EyePoint Pharmaceuticals : EYPT

EYPT

Stock Data

$16.93

$0.53 (3.23%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

EyePoint Pharmaceuticals, based in Watertown, Massachusetts, focuses on creating treatments for serious retinal diseases. With a strong emphasis on innovation, the company develops drugs that offer sustained release directly into the eye, using its unique Durasert E technology. Its leading candidate, EYP-1901, aims to tackle VEGF-mediated retinal diseases through a novel approach combining a tyrosine kinase inhibitor with sustained delivery technology. EyePoint, originally known as pSivida Corp., rebranded in 2018, continuing its mission to advance eye care.

All EyePoint Pharmaceuticals Articles

7 Articles

Trey Thoelcke | Sep 29, 2024 at 9:15 AM EDT

Check Out Last Week’s Big Insider Buying: Biotechs, Energy, and More

A public offering of shares this past week prompted a huge purchase from a beneficial owner. Meanwhile, a couple of…

Trey Thoelcke | May 12, 2024 at 9:15 AM EDT

Notable Insider Buying at Disney and More This Week

Even as the earnings-reporting season has begun to slow in the past week, some insiders and beneficial owners were adding…

Trey Thoelcke | Apr 28, 2024 at 8:15 AM EDT

These Biotechs and IPOs Inspire Big Insider Buying

Initial public offerings and a secondary offering inspired insiders to pick up some shares of these biotech companies and others.

Trey Thoelcke | Feb 5, 2024 at 12:09 PM EST

Insider Buying at These Biotechs Is Huge

As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at…

Trey Thoelcke | Jan 17, 2024 at 12:59 PM EST

New Year’s Insider Buying Focuses on Biotechs

As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on…

Trey Thoelcke | Dec 16, 2023 at 9:49 AM EST

Huge Warren Buffett Purchase Highlights Hot Insider Buying

Warren Buffett's Berkshire Hathaway has bolstered its stake in Occidental Petroleum with a huge purchase of shares. Insider buying is…

Trey Thoelcke | Dec 14, 2023 at 8:50 AM EST

What Has Insiders Eyeing This Biotech Stock

A biotech stock rallying on encouraging trial results prompted insider buying and selling. A specialty retailer and others saw insider…